Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
21%
ALSO IN PPH
PPH
27
HOLDINGS
17%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.3% | 21.0% | 16.3% |
 |
NOVO-NORDISK A/S-SPONS ADR | 16.4% | 7.2% | 7.2% |
|
PFIZER INC | 3.8% | 4.8% | 3.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.7% | 4.5% | 3.7% |
OZEM Overweight Relative to PPH
|
NOVO-NORDISK A/S-SPONS ADR | 9.2% |
|
VIKING THERAPEUTICS, INC. | 5.9% |
|
ZEALAND PHARMA A/S | 5.3% |
 |
ROCHE HOLDING LTD | 5.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.7% |
|
AMGEN INC | 3.6% |
 |
INNOVENT BIOLOGICS, INC. | 3.5% |
|
REGENERON PHARMACEUTICALS | 2.8% |
|
TERNS PHARMACEUTICALS, INC. | 2.7% |
 |
HANMI PHARM CO LTD | 2.7% |
OZEM Underweight Relative to PPH
|
NOVARTIS AG-ADR | -9.6% |
|
MERCK & CO. INC. | -7.6% |
|
MCKESSON CORP | -4.9% |
 |
SANOFI-AVENTIS-ADR | -4.7% |
|
ELI LILLY & CO | -4.7% |
|
JOHNSON & JOHNSON | -4.7% |
|
ABBVIE INC | -4.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.6% |
|
ZOETIS INC | -4.2% |
|
BRISTOL-MYERS SQUIBB CO | -4.0% |